MIUChon™

MIUChon™

(2020’ IIT, 2022’ SIT Clinical trials are scheduled to be conducted)

MIUChon™ is a cellular therapeutic agent consisted of chondrocytes derived from homozygous iPSCs.
Unlike other cellular therapeutics, MIUChon™ is an injectable organoid-type osteoarthritis treatment.

We have CiSTEM's unique chondrocyte differentiation technology using induced pluripotent stem cells, and secured technology for high-quality chondrocyte production.

Research papers for the production and quality improvement of chondrocytes derived from induced pluripotent stem cells.